Kevin is President of the Pharmaceutical Division of Biomedical Systems. He has been with Biomedical Systems 24 years and has been involved with the clinical trial industry for the past 22 years.  In his current capacity, Mr. Klingler oversees the centralized diagnostic services provided to pharmaceutical and biotechnology companies, device manufacturers, and contract research organizations in Phase I-IV trials around the world. The Pharmaceutical Division has offices in St. Louis, Missouri and Brussels Belgium and is currently participating in over 300 clinical trials in 70 countries.

Mr. Klingler has spoken at many pharmaceutical industry conferences around the world, has participated in round table discussions at numerous meetings and in October 2002 co-chaired the DIA Sponsored “ECG’s in Clinical Trials” Seminar.  He received his BS in Finance and Masters in Business Administration from St. Louis University.